Literature DB >> 15795309

Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections.

Amanda Corcoran, Sean Doyle, Jean-Pierre Allain, Daniel Candotti, Armen Parsyan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15795309      PMCID： PMC1069586          DOI： 10.1128/JVI.79.8.5238-5239.2005

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  11 in total

1.  Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.

Authors:  J A Jordan
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Genetic diversity within human erythroviruses: identification of three genotypes.

Authors:  Annabelle Servant; Syria Laperche; Francis Lallemand; Valérie Marinho; Guillemette De Saint Maur; Jean François Meritet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.

Authors:  E Manaresi; G Gallinella; M Zerbini; S Venturoli; G Gentilomi; M Musiani
Journal:  J Med Virol       Date:  1999-02       Impact factor: 2.327

4.  [Comparative study of the prevalence of Herpesviridae in an African population and a European population].

Authors:  J F Bonnici; M Babin; H J Fleury; P du Pasquier; A Samb
Journal:  Bull Soc Pathol Exot Filiales       Date:  1985

5.  Seroprevalence of viral childhood infections in Eritrea.

Authors:  T Tolfvenstam; M Enbom; H Ghebrekidan; U Rudén; A Linde; M Grandien; B Wahren
Journal:  J Clin Virol       Date:  2000-02       Impact factor: 3.168

Review 6.  Human parvovirus B19: relevance in internal medicine.

Authors:  A M van Elsacker-Niele; A C Kroes
Journal:  Neth J Med       Date:  1999-06       Impact factor: 1.422

7.  Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.

Authors:  Erik D Heegaard; Klaus Qvortrup; Jesper Christensen
Journal:  J Med Virol       Date:  2002-02       Impact factor: 2.327

8.  Identification and characterization of persistent human erythrovirus infection in blood donor samples.

Authors:  Daniel Candotti; Nermin Etiz; Armen Parsyan; Jean-Pierre Allain
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.

Authors:  M Söderlund; C S Brown; W J Spaan; L Hedman; K Hedman
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

10.  Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa.

Authors:  D Ablashi; L Chatlynne; H Cooper; D Thomas; M Yadav; A W Norhanom; A K Chandana; V Churdboonchart; S A Kulpradist; M Patnaik; K Liegmann; R Masood; M Reitz; F Cleghorn; A Manns; P H Levine; C Rabkin; R Biggar; F Jensen; P Gill; N Jack; J Edwards; J Whitman; C Boshoff
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640
View more
  2 in total

1.  Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic.

Authors:  Armen Parsyan; Shane Kerr; Shirley Owusu-Ofori; Gordon Elliott; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

Review 2.  Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations.

Authors:  Amita Jain; Ravi Kant
Journal:  Indian J Med Res       Date:  2018-03       Impact factor: 2.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.